维普期刊资源整合服务平台（V6.5）

443篇 您的检索式：作者名="Saltz"

选中清除导出查看参考文献查看引证文献引用追踪共23页首页上一页第1页下一页末页 /23 跳转

	题名	作者	年代	出处	被引量
1	Using the movement patterns of reintroduced animals to improve reintroduction success显示文摘	Oded BERGER-TAL David SALTZ	2014	Current Zoology2014，60，4：	3
2	Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer显示文摘	Kopetz Scott Desai Jayesh Chan Emily Hecht Joel Randolph O’Dwyer Peter J. Maru Dipen Morris Van Janku Filip Dasari Arvind Chung Woonbook Issa Jean-Pierre J. Gibbs Peter James Brian Powis Garth Nolop Keith B. Bhattacharya Suman Saltz Leonard	2015	Journal of Clinical Oncology2015，，34：	2
3	Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant Therapy显示文摘	James D. Smith Jeannine A. Ruby Karyn A. Goodman Leonard B. Saltz José G. Guillem Martin R. Weiser Larissa K. Temple Garrett M. Nash Philip B. Paty	2012	Annals of Surgery2012，，6：	2
4	Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:a randomized phase Ⅲ study显示文摘	Saltz LB Clarke S Díaz-Rubio E		0，，12：	2
5	Bevacizumab in combination with oxaliplatin - based chemotherapy as first - line therapy in metastatic colorectal cancer: a randomized phase Ⅲ study显示文摘	SALTZ L B CLARKE S DIAZ -RUBIO E	2008	J Clin Oncol2008，26，12：	1
6	Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer显示文摘	Saltz LB Cox JV Blanke C	2000	N Engl J Med2000，343，13：	1
7	Urinary cortisol, urea nitrogen excretion, and winter survival in mule deer fawns 显示文摘	Saltz D White G C Bartmann R M	1992	J Wildl Manage1992，56，：	1
8	Panitumumab 显示文摘	SALTZ L EASLEY C KIRKPATRICK P	2006	Nat Rev Drug Discov2006，5，12：	1
9	lrinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer显示文摘	Saltz LB Cox JV Blanke C	2000	NEngl JMed2000，343，13：	1
10	Bevacizumab in combination with oxaliplatin-based chemotherapy as frist-line therapy in metastatic colorectal cancer:a randomized phase Ⅲ study显示文摘	Saltz LB Clarke S Diza-Rubio E		0，，20：	1
11	'Supercharging' the rectus abdominis muscle to provide a single flap for cover of large mediastinal wound defects显示文摘	Pemia LR Miller HL Saltz R	1991	Br J Plast Surg1991，44，4：	1
12	Phase Ⅱ trial of weekly irintecan plus cisplatin in advanced esophageal cancer 显示文摘	Ilson DH Saltz I Enzinger P	1999	J Clin Oncol1999，17，10：	1
13	Phase Ⅱ trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor显示文摘	SALTZ L B MEROPOL N J LOEHRER P J Sr	2004	J Clin Oncol2004，22，7：	1
14	The effects of clozapine on tardive dyskinesia显示文摘	Saltz C John C	1991	Br J Psychiatry1991，158，4：	1
15	Phase lI trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor显示文摘	Saltz LB Meropol N J Loehrer PJ Sr	2004	J Clin Oncol2004，22，7：	1
16	Bevacizunmb in combination with oxaliplatin-based chemotherapy as first line therapy in metastatic colorectal cancer: a randomized phasem study显示文摘	Saltz LB Clarke S Diaz-rubio E	2008	J Clin Oncol2008，26，12：	1
17	Thirteen years of experience with the endoscopic midface lift显示文摘	Saltz R Ohana B	2012	Aesthet Surg J2012，32，8：	1
18	Outcome of primary tumor in patients with synchronous stage Ⅳ colorectal cancer receiving combination chemotherapy without surgery as initial treatment显示文摘	Poultsides GA Servais EL Saltz LB		0，，20：	1
19	Irinotecan plus fluorouracil/leucovorin(IFL) versus fluorouracil/leucovorin alone(FL) in stage Ⅲ colon cancer(intergroup trial CALGB C89803)显示文摘	Saltz LB Niedzwiecki D Hollis D	2004	Proc Am Soc Clin Oncol2004，，：	1
20	A multicenter phase Ⅱ study of irinotecan (CPT) , cisplatin ( CIS ), and bevacizumab ( BEV ) in patients with unresectable or metastatic gastric or gastroesophageal(GEJ) adenocarcinoma显示文摘	Shah M A llson D Saltz E	2005	Proc Am Soc Clin Oncoi2005，23，：	1

返回顶部每页显示：

共23页首页上一页第1页下一页末页 /23 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示